Effects of cholecystokinin, caerulein and pentagastrin on electrical behavior of myenteric neurons. 1985

P R Nemeth, and D H Zafirov, and J D Wood

Intracellular methods were used to record the electrical behavior of myenteric neurons from guinea-pig ileum in vitro. Cholecystokinin-octapeptide (CCK-8) at 1 to 100 microM in the ejection pipettes were applied to the neurons by pressure microejection. CCK-8 (0.01 to 1 microM) and caerulein (0.01 to 0.1 microM) were applied also in the superfusion solution. CCK-8, applied by either method, evoked a long-lasting depolarization of the cell membranes that was associated with an increase in the input resistance, suppression of hyperpolarizing afterpotentials and enhanced excitability. The enhanced excitability was reflected by increased probability of action potential discharge during membrane depolarization by intracellularly injected current. Caerulein evoked the same excitatory responses as CCK-8. The actions of both agents simulated slow synaptic excitation in the neurons. In another group of AH/type 2 neurons, CCK-8 evoked a long-lasting membrane hyperpolarization and decreased input resistance that mimicked stimulus-evoked slow inhibitory postsynaptic potentials. Hyperpolarizing responses were never evoked by caerulein. About 25% of tested neurons failed to respond to CCK-8 and 70% did not respond to caerulein. Pentagastrin (1 microM in the superfusion solution) did not affect the electrical behavior of the neurons. The results are consistent with a neurotransmitter role for cholecystokinin that could be either excitatory of inhibitory in the enteric nervous system.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009197 Myenteric Plexus One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38) Auerbach's Plexus,Auerbach Plexus,Auerbachs Plexus,Plexus, Auerbach's,Plexus, Myenteric
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D011377 Proglumide A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Xylamide,Milid,Xilamide
D002108 Ceruletide A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction. Caerulein,Cerulein,Ceruletid,FI-6934,Takus,FI 6934,FI6934
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012844 Sincalide An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas. CCK-8,Cholecystokinin Octapeptide,CCK-OP,Cholecystokinin Pancreozymin C-Terminal Octapeptide,H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,Kinevac,OP-CCK,SQ-19,844,SQ-19844,Syncalide,Cholecystokinin Pancreozymin C Terminal Octapeptide,SQ 19,844,SQ 19844,SQ19,844,SQ19844

Related Publications

P R Nemeth, and D H Zafirov, and J D Wood
February 1985, Experientia,
P R Nemeth, and D H Zafirov, and J D Wood
January 1997, Polish journal of pharmacology,
P R Nemeth, and D H Zafirov, and J D Wood
November 1982, European journal of pharmacology,
P R Nemeth, and D H Zafirov, and J D Wood
January 1972, Scandinavian journal of gastroenterology,
P R Nemeth, and D H Zafirov, and J D Wood
January 1986, Psychoneuroendocrinology,
P R Nemeth, and D H Zafirov, and J D Wood
April 1988, The American journal of physiology,
P R Nemeth, and D H Zafirov, and J D Wood
August 1982, Neuropharmacology,
P R Nemeth, and D H Zafirov, and J D Wood
December 1984, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!